Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.85% | $5.37B | €438.14B | 72.70% | 76 Outperform | |
| Roche Holding AG | 1.04% | $3.04B | CHF272.90B | 26.73% | 73 Outperform | |
| HSBC Holdings | 0.99% | $2.88B | £213.83B | 42.06% | 80 Outperform | |
| Novartis AG | 0.93% | $2.71B | CHF234.59B | 22.14% | 80 Outperform | |
| AstraZeneca | 0.91% | $2.66B | $301.48B | 20.11% | 80 Outperform | |
| Nestlé SA | 0.79% | $2.30B | CHF202.95B | 0.58% | 71 Outperform | |
| Toyota Motor | 0.79% | $2.29B | ¥45.81T | 23.81% | 80 Outperform | |
| Royal Bank Of Canada | 0.77% | $2.24B | $228.95B | 42.10% | 75 Outperform | |
| Shell (UK) | 0.73% | $2.12B | £176.52B | 22.65% | 73 Outperform | |
| Siemens | 0.73% | $2.11B | €171.36B | -4.46% | 74 Outperform |